Skip to main content
Premium Trial:

Request an Annual Quote

Eric Topol, Michael Stapleton, Vivien Bonazzi, Clive Seymour

Premium

Eric Topol has been appointed to the scientific advisory board of Perlegen. He is chief academic officer of The Cleveland Clinic Foundation and provost of the Cleveland Clinic Lerner College of Medicine of Case Western University.


Michael Stapleton has become general manager and vice president, and Vivien Bonazzi director of research and development at Invitrogen’s bioinformatics business. Stapleton previously worked at Accelrys, where he was executive vice president and COO. He holds a doctorate and master’s degrees in chemical physics, and a bachelor’s degree in chemistry from Southampton University in the UK.

Bonazzi joins Invitrogen from Celera Genomics, where she was director of product development and scientific management.


Clive Seymour has become vice president for Asia-Pacific at Bruker BioSciences. Seymour was previously vice president for the Asia-Pacific region at Biacore. Prior to that, he was vice president corporate communications and head of life science research business unit at Biacore. He has also been European market area manager for Pharmacia Biotech Europe, and regional marketing and sales manager for Pharmacia Biotech Asia-Pacific.

 

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.